What is the current valuation of the GMP Testing Market as of 2024?

The GMP Testing Market was valued at 2.0 USD Billion in 2024. Read More

What is the projected market valuation for the GMP Testing Market in 2035?

The GMP Testing Market is projected to reach 4.211 USD Billion by 2035. Read More

What is the expected CAGR for the GMP Testing Market during the forecast period 2025 - 2035?

The expected CAGR for the GMP Testing Market during the forecast period 2025 - 2035 is 7.0%. Read More

Which service type segment is anticipated to show the highest growth in the GMP Testing Market?

The Product Validation Testing segment is expected to grow from 0.8 USD Billion in 2024 to 1.5 USD Billion by 2035. Read More

How do pharmaceutical and biopharmaceutical companies contribute to the GMP Testing Market?

Pharmaceutical and biopharmaceutical companies accounted for a market size of 1.2 USD Billion in 2024, projected to grow to 2.5 USD Billion by 2035. Read More

What role do key players like SGS and Eurofins Scientific play in the GMP Testing Market?

Key players such as SGS and Eurofins Scientific are instrumental in driving innovation and quality assurance within the GMP Testing Market. Read More

What is the market size for bioanalytical services in the GMP Testing Market?

Bioanalytical Services were valued at 0.5 USD Billion in 2024 and are expected to reach 1.0 USD Billion by 2035. Read More

What is the significance of packaging and shelf-life testing in the GMP Testing Market?

Packaging and Shelf-Life Testing is projected to grow from 0.4 USD Billion in 2024 to 0.8 USD Billion by 2035, indicating its increasing importance. Read More

How do medical device companies impact the GMP Testing Market?

Medical device companies represented a market size of 0.8 USD Billion in 2024, with expectations to grow to 1.7 USD Billion by 2035. Read More

What are the other service types included in the GMP Testing Market, and what is their growth outlook?

Other Service Types were valued at 0.3 USD Billion in 2024 and are projected to increase to 0.6 USD Billion by 2035. Read More

GMP Testing Market

ID: MRFR/HC/20517-HCR

128 Pages

Satyendra Maurya

Last Updated: June 08, 2026

GMP Testing Market Research Report Information By Service Type (Product Validation Testing, Bioanalytical Services, Packaging and Shelf-Life Testing, And Other Service Types), By End-Use (Pharmaceutical and Biopharmaceutical Companies And Medical Devices Companies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Service Type (USD Billion)
  1. 4.1.1 Product Validation Testing
  2. 4.1.2 Bioanalytical Services
  3. 4.1.3 Packaging and Shelf-Life Testing
  4. 4.1.4 Other Service Types
2. 4.2 Healthcare, BY End-use (USD Billion)
  1. 4.2.1 Pharmaceutical and Biopharmaceutical Companies
  2. 4.2.2 Medical Devices Companies
3. 4.3 Healthcare, BY Region (USD Billion)
  1. 4.3.1 North America
    1. 4.3.1.1 US
    2. 4.3.1.2 Canada
  2. 4.3.2 Europe
    1. 4.3.2.1 Germany
    2. 4.3.2.2 UK
    3. 4.3.2.3 France
    4. 4.3.2.4 Russia
    5. 4.3.2.5 Italy
    6. 4.3.2.6 Spain
    7. 4.3.2.7 Rest of Europe
  3. 4.3.3 APAC
    1. 4.3.3.1 China
    2. 4.3.3.2 India
    3. 4.3.3.3 Japan
    4. 4.3.3.4 South Korea
    5. 4.3.3.5 Malaysia
    6. 4.3.3.6 Thailand
    7. 4.3.3.7 Indonesia
    8. 4.3.3.8 Rest of APAC
  4. 4.3.4 South America
    1. 4.3.4.1 Brazil
    2. 4.3.4.2 Mexico
    3. 4.3.4.3 Argentina
    4. 4.3.4.4 Rest of South America
  5. 4.3.5 MEA
    1. 4.3.5.1 GCC Countries
    2. 4.3.5.2 South Africa
    3. 4.3.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 SGS (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Eurofins Scientific (LU)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Intertek (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Charles River Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Pace Analytical Services (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Bureau Veritas (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 TÜV SÜD (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Merck KGaA (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Labcorp (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY SERVICE TYPE
4. 6.4 US MARKET ANALYSIS BY END-USE
5. 6.5 CANADA MARKET ANALYSIS BY SERVICE TYPE
6. 6.6 CANADA MARKET ANALYSIS BY END-USE
7. 6.7 EUROPE MARKET ANALYSIS
8. 6.8 GERMANY MARKET ANALYSIS BY SERVICE TYPE
9. 6.9 GERMANY MARKET ANALYSIS BY END-USE
10. 6.10 UK MARKET ANALYSIS BY SERVICE TYPE
11. 6.11 UK MARKET ANALYSIS BY END-USE
12. 6.12 FRANCE MARKET ANALYSIS BY SERVICE TYPE
13. 6.13 FRANCE MARKET ANALYSIS BY END-USE
14. 6.14 RUSSIA MARKET ANALYSIS BY SERVICE TYPE
15. 6.15 RUSSIA MARKET ANALYSIS BY END-USE
16. 6.16 ITALY MARKET ANALYSIS BY SERVICE TYPE
17. 6.17 ITALY MARKET ANALYSIS BY END-USE
18. 6.18 SPAIN MARKET ANALYSIS BY SERVICE TYPE
19. 6.19 SPAIN MARKET ANALYSIS BY END-USE
20. 6.20 REST OF EUROPE MARKET ANALYSIS BY SERVICE TYPE
21. 6.21 REST OF EUROPE MARKET ANALYSIS BY END-USE
22. 6.22 APAC MARKET ANALYSIS
23. 6.23 CHINA MARKET ANALYSIS BY SERVICE TYPE
24. 6.24 CHINA MARKET ANALYSIS BY END-USE
25. 6.25 INDIA MARKET ANALYSIS BY SERVICE TYPE
26. 6.26 INDIA MARKET ANALYSIS BY END-USE
27. 6.27 JAPAN MARKET ANALYSIS BY SERVICE TYPE
28. 6.28 JAPAN MARKET ANALYSIS BY END-USE
29. 6.29 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE
30. 6.30 SOUTH KOREA MARKET ANALYSIS BY END-USE
31. 6.31 MALAYSIA MARKET ANALYSIS BY SERVICE TYPE
32. 6.32 MALAYSIA MARKET ANALYSIS BY END-USE
33. 6.33 THAILAND MARKET ANALYSIS BY SERVICE TYPE
34. 6.34 THAILAND MARKET ANALYSIS BY END-USE
35. 6.35 INDONESIA MARKET ANALYSIS BY SERVICE TYPE
36. 6.36 INDONESIA MARKET ANALYSIS BY END-USE
37. 6.37 REST OF APAC MARKET ANALYSIS BY SERVICE TYPE
38. 6.38 REST OF APAC MARKET ANALYSIS BY END-USE
39. 6.39 SOUTH AMERICA MARKET ANALYSIS
40. 6.40 BRAZIL MARKET ANALYSIS BY SERVICE TYPE
41. 6.41 BRAZIL MARKET ANALYSIS BY END-USE
42. 6.42 MEXICO MARKET ANALYSIS BY SERVICE TYPE
43. 6.43 MEXICO MARKET ANALYSIS BY END-USE
44. 6.44 ARGENTINA MARKET ANALYSIS BY SERVICE TYPE
45. 6.45 ARGENTINA MARKET ANALYSIS BY END-USE
46. 6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
47. 6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE
48. 6.48 MEA MARKET ANALYSIS
49. 6.49 GCC COUNTRIES MARKET ANALYSIS BY SERVICE TYPE
50. 6.50 GCC COUNTRIES MARKET ANALYSIS BY END-USE
51. 6.51 SOUTH AFRICA MARKET ANALYSIS BY SERVICE TYPE
52. 6.52 SOUTH AFRICA MARKET ANALYSIS BY END-USE
53. 6.53 REST OF MEA MARKET ANALYSIS BY SERVICE TYPE
54. 6.54 REST OF MEA MARKET ANALYSIS BY END-USE
55. 6.55 KEY BUYING CRITERIA OF HEALTHCARE
56. 6.56 RESEARCH PROCESS OF MRFR
57. 6.57 DRO ANALYSIS OF HEALTHCARE
58. 6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
59. 6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
60. 6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
61. 6.61 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
62. 6.62 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
63. 6.63 HEALTHCARE, BY END-USE, 2024 (% SHARE)
64. 6.64 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion)
65. 6.65 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY END-USE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY END-USE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY END-USE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY END-USE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY END-USE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY END-USE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY END-USE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY END-USE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY END-USE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY END-USE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY END-USE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY END-USE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY END-USE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY END-USE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY END-USE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY END-USE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY END-USE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY END-USE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY END-USE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY END-USE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY END-USE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY END-USE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY END-USE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY END-USE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY END-USE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY END-USE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY END-USE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY END-USE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY END-USE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Service Type (USD Billion, 2025-2035)

Product Validation Testing
Bioanalytical Services
Packaging and Shelf-Life Testing
Other Service Types

Healthcare By End-use (USD Billion, 2025-2035)

Pharmaceutical and Biopharmaceutical Companies
Medical Devices Companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”